Trulicity® 1.5 mg is a once-weekly GLP-1 receptor agonist injection prescribed to help adults with type 2 diabetes manage blood sugar levels. Each single-use, prefilled pen delivers 1.5 mg of dulaglutide in 0.5 mL and is designed for ease of use with a hidden needle and one-step activation. Trulicity not only helps with glycemic control but also reduces the risk of major cardiovascular events in patients with type 2 diabetes and established heart disease.

Features:

• Higher-Dose Therapy: 1.5 mg dose may offer enhanced blood sugar control for patients needing more than the starting dose.

• Once-Weekly Dosing: Designed for convenience with just one injection per week.

• Prefilled, Ready-to-Use Pens: No assembly, no need to see or handle a needle.

• Proven Cardiovascular Benefits: Helps lower the risk of heart attack and stroke in certain patients with type 2 diabetes.

• Monthly Supply: Contains 4 single-dose pens for a 4-week treatment course.